Between the massive cyberattack on Optum’s Change Healthcare unit and the recent attack on St. Louis-based health system Ascension, it seems like there is a new healthcare cybersecurity incident each ...

HHS proposed changes that would roll back many Biden-era policies, eliminate most health tech certification criteria,and ...

Individual Coverage Health Reimbursement Arrangements (ICHRAs) are continuing to gain the interest of employers and investors. And Venteur’s $20 million Series A round announced on Tuesday is another ...

Epic is welcoming generative AI’s entrance into healthcare. The company is expanding its existing collaboration with Microsoft by integrating OpenAI services, such as GPT-4, into its EHR. The partners ...

Like most industries, healthcare is experiencing financial pressure and unprecedented AI advancements. Organizations are also grappling with a political and economic environment that is more dynamic ...

This roundup is published monthly. It is meant to highlight some of healthcare’s recent hiring news and is not intended to be comprehensive. If you have news about an executive appointment, ...

“We are fundamentally trying to change how the U.S. healthcare industry interacts with provider data.” That was the lofty goal that Anshul Rathi, founder and CEO of provider intelligence platform ...

While value-based payment models seem great in theory, research shows that many primary care providers aren’t partaking in these models. Over the last 14 years, the Centers for Medicare and Medicaid ...

Congress passed a continuing resolution last week to fund the federal government through September 30 and avoid a government shutdown. The legislation extended some key healthcare provisions, letting ...

New research emerged this month shining light on the need for wider use of continuous glucose monitors (CGMs). The study — which was conducted by CCS, a chronic care management company — analyzed data ...

PCR is a mainstay in diagnostics, but whether a sample is collected at a clinic or at home, such tests require sending a sample to a lab and then waiting for results. A new FDA authorized ...

An experimental GLP-1 obesity drug from Terns Pharmaceuticals led to a 5.5% reduction in body weight in a small study, continuing to build its case as a potential oral alternative to currently ...